Previous Article | Next Article ![]()
Journal of Virology, May 2000, p. 3948-3952, Vol. 74, No. 9
Institut National de la Santé et de la
Recherche Médicale U4631 and
Laboratoire de Virologie,2 Institut
de Biologie, 44093 Nantes Cedex 1, France
Received 10 November 1999/Accepted 29 January 2000
Cytotoxic T lymphocytes (CTLs) play a central role in the control
of persistent human cytomegalovirus (HCMV) infection in healthy virus
carriers. Previous analyses of the specificity of HCMV-reactive
CD8+ CTLs drawn from in vitro models in which
antigen-presenting cells were autologous fibroblasts infected with
laboratory HCMV strains have shown focusing of CTL responses against
the major tegument protein, pp65. By contrast, the 72-kDa major
immediate-early protein (IE1) was identified as a minor target for this
response. Here we have studied the fine specificity and T-cell-receptor
features of T-cell clones generated against autologous B lymphoblastoid cell lines stably transfected with HCMV cDNA coding for either pp65 or
a natural variant of IE1. This strategy allowed efficient generation of
T-cell clones against IE1 and pp65 and led to the identification of
several new IE1 and pp65 epitopes, including some located in
polymorphic regions of IE1. Such an approach may provide relevant
information about the characteristics of the CTL response to IE1 and
the effect of viral polymorphism on the immune response against HCMV.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Generation of Cytomegalovirus-Specific Human T-Lymphocyte Clones
by Using Autologous B-Lymphoblastoid Cells with Stable Expression of
pp65 or IE1 Proteins: a Tool To Study the Fine Specificity of the
Antiviral Response
*
Corresponding author. Mailing address: INSERM U463,
Institut de Biologie, 9 quai Moncousu, 44093 Nantes Cedex 1, France.
Phone: (33) 02-40-08-47-12. Fax: (33) 02-40-35-66-97. E-mail:
mmhallet{at}nantes.inserm.fr.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|